Xue Mei

Xue Mei


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
WJWenqing Ji
Wenqing Ji
TWTiantian Wan
Tiantian Wan
FZFang Zhang
Fang Zhang
XZXiaomei Zhu
Xiaomei Zhu
SGShubin Guo
Shubin Guo
XMXue Mei
Xue Mei
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis-induced circulatory and cardiac dysfunction is associated with high mortality rates. Mitophagy, a specific form of autophagy, is excessively activated in lipopolysaccharide-induced myocardial injury. The present study investigated whether aldehyde dehydrogenase 2 (ALDH2) regulates mitophagy in sepsis-induced myocardial dysfunction. After lipopolysaccharide administration, cardiac dysfunction, inflammatory cell infiltration, biochemical indicators of myocardial cell injury, and cardiomyocyte apoptosis were ameliorated in mice by ALDH2 activation or overexpression. In contrast, cardiac dysfunction and cardiomyocyte apoptosis were exacerbated in mice followed ALDH2 inhibition. Moreover, ALDH2 activation or overexpression regulated mitophagy by suppressing the expression of phosphatase and tensin homolog-induced putative kinase 1 (PINK1)/Parkin, by preventing the accumulation of 4-hydroxy-trans-nonenal. Conversely, ALDH2 inhibition promoted the expression of LC3B by increasing 4-hydroxy-trans-2-nonenal accumulation. Consequently, ALDH2 may protect the heart from lipopolysaccharide-induced injury by suppressing PINK1/Parkin-dependent mitophagy.

1 May 2018 in Medicine
Verified
Journal Article
Open access
PDF file
SYShaoxin Yuan
Shaoxin Yuan
YGYusong Gao
Yusong Gao
WJWenqing Ji
Wenqing Ji
JSJunshuai Song
Junshuai Song
XMXue Mei
Xue Mei
The aim of this study was to assess the ability of acute physiology and chronic health evaluation II (APACHE II) score, poisoning severity score (PSS) as well as sequential organ failure assessment (SOFA) score combining with lactate (Lac) to predict mortality in the Emergency Department (ED) patients who were poisoned with organophosphate. A retrospective review of 59 stands-compliant patients was carried out. Receiver operating characteristic (ROC) curves were constructed based on the APACHE II score, PSS, SOFA score with or without Lac, respectively, and the areas under the ROC curve (AUCs) were determined to assess predictive value. According to SOFA–Lac (a combination of SOFA and Lac) classification standard, acute organophosphate pesticide poisoning (AOPP) patients were divided into low-risk and high-risk groups. Then mortality rates were compared between risk levels. Between survivors and non-survivors, there were significant differences in the APACHE II score, PSS, SOFA score, and Lac (all P < .05). The AUCs of the APACHE II score, PSS, and SOFA score were 0.876, 0.811, and 0.837, respectively. However, after combining with Lac, the AUCs were 0.922, 0.878, and 0.956, respectively. According to SOFA–Lac, the mortality of high-risk group was significantly higher than low-risk group (P < .05) and the patients of the non-survival group were all at high risk. These data suggest the APACHE II score, PSS, SOFA score can all predict the prognosis of AOPP patients. For its simplicity and objectivity, the SOFA score is a superior predictor. Lac significantly improved the predictive abilities of the 3 scoring systems, especially for the SOFA score. The SOFA–Lac system effectively distinguished the high-risk group from the low-risk group. Therefore, the SOFA–Lac system is significantly better at predicting mortality in AOPP patients.

25 September 2024 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
XZXiangqun Zhang
Xiangqun Zhang
JWJunyuan Wu
Junyuan Wu
HDHongmeng Dong
Hongmeng Dong
NSNa Shang
Na Shang
YLYixuan Li
Yixuan Li
XMXue Mei
Xue Mei
Objective: To analyze the impact of different methods of Vitamin D administration on the prognosis of COVID-19 patients.Methods: A comprehensive literature search was conducted across four databases: PubMed, Embase, Web of Science, and Cochrane, up to January 5, 2024. Eligible studies included randomized controlled trials and cohort studies that compared Vitamin D supplementation with control groups in COVID-19 patients. Outcomes of interest were mortality rate, ICU (Intensive Care Unit) admission rate, length of hospital stay, and endotracheal intubation rate. Subgroup analyses were performed based on the dosing regimen (single-dose vs. continuous-dose), total Vitamin D intake within 14 days (≥100,000 IU vs. <100,000 IU), and baseline serum Vitamin D levels (deficient group: 25OHD < 30 ng/mL vs. non-restricted group). A random-effects model was employed for meta-analysis to account for heterogeneity among studies.Results: A total of 21 studies involving 4,553 participants were included. In terms of mortality, Vitamin D supplementation significantly reduced the mortality rate (RR = 0.72, 95% CI: 0.54–0.94, I2 = 54%, p = 0.02), with continuous dosing being more effective (RR = 0.53, 95% CI: 0.34–0.83, I2 = 55%, p = 0.006) compared to single-dose (RR = 0.88, 95% CI: 0.69–1.12, I2 = 21%, p = 0.3), and lower total doses (<100,000 IU) showing greater benefit (RR = 0.30, 95% CI: 0.21–0.44, I2 = 0%, p < 0.0001). Mortality was significantly reduced in the Vitamin D-deficient group (25OHD < 30 ng/mL) (RR = 0.73, 95% CI: 0.59–0.89, I2 = 0%, p = 0.002) but not in the non-restricted group. Regarding ICU admission, supplementation reduced ICU admission rates (RR = 0.58, 95% CI: 0.38–0.88, I2 = 74%, p = 0.01), with continuous dosing (RR = 0.44, 95% CI: 0.22–0.90, I2 = 74%, p = 0.02) being more effective than single-dose (RR = 0.79, 95% CI: 0.61–1.03, I2 = 22%, p = 0.08), and lower doses (<100,000 IU) providing more significant reduction (RR = 0.31, 95% CI: 0.21–0.47, I2 = 0%, p = 0.001). ICU admission rates were significantly reduced in the Vitamin D-deficient group (RR = 0.63, 95% CI: 0.42–0.93, I2 = 0%, p = 0.02) but not in the non-restricted group (RR = 0.59, 95% CI: 0.32–1.11, I2 = 86%, p = 0.1). For length of hospital stay, no significant differences were observed between Vitamin D and control groups (MD = −1, 95% CI: −2.16 to 0.16, p = 0.13), and subgroup analyses by dosing regimen, total dose, and baseline Vitamin D levels also showed no significant differences. Similarly, for endotracheal intubation, there was no significant difference in intubation rates between groups (RR = 0.78, 95% CI: 0.56–1.08, p = 0.13), and subgroup analyses confirmed no significant effect of different dosing strategies or baseline Vitamin D status on intubation rates.Conclusion: Vitamin D supplementation improves clinical outcomes in COVID-19 patients by reducing mortality and ICU admission rates, particularly when administered continuously with a total dose of less than 100,000 IU over 14 days, and among those with baseline Vitamin D deficiency (25OHD < 30 ng/mL). However, there were no significant effects on the length of hospital stay or endotracheal intubation rates, regardless of the dosing regimen or baseline Vitamin D levels. These findings emphasize the importance of considering both the total dose over 14 days and baseline Vitamin D status to optimize therapeutic benefits.

23 September 2025 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
SGShubin Guo
Shubin Guo
QLQiujing Li
Qiujing Li
HZHaijing Zhou
Haijing Zhou
XZXiangqun Zhang
Xiangqun Zhang
SGShu-Bin Guo
Shu-Bin Guo
XMXue Mei
Xue Mei
To evaluate the applicability of the Global Leadership Initiative on Malnutrition (GLIM) criteria in older patients with sepsis and to compare the predictive validity for 28-day mortality of different muscle mass assessment methods in the emergency department. Prospective cohort study. Emergency department. Older patients (≥65 years) with sepsis. Muscle mass was assessed using three methods: (1) the skeletal muscle index at the third lumbar vertebra (L3) on computed tomography (CT) scans; (2) calf circumference (CC), and (3) mid-upper-arm circumference (MAC). Cox regression analysis was performed to assess the association between the GLIM criteria and 28-day all-cause mortality. Additionally, the C-statistic, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate the predictive validity of the three instruments. Survival curves were assessed using the Kaplan-Meier method and compared using the log-rank test. A total of 598 patients with sepsis were included. The prevalence of malnutrition according to GLIM-CT, GLIM-CC, and GLIM-MAC was 53.3%, 63.0%, and 40.8%, respectively. Cox regression analysis revealed that the GLIM criteria were independent risk factors for all-cause 28-day mortality. Incorporation of GLIM-CT, GLIM-CC, or GLIM-MAC into a base model significantly improved the C-statistic. The model including GLIM-CT had the highest C-statistic, improving the C-statistic of the base model from 0.780 (95% confidence interval [CI]: 0.741-0.819) to 0.823 (95% CI: 0.789-0.857). This improvement in risk prediction was also confirmed via category-free NRI and IDI, suggesting that GLIM-CT had the best performance. Kaplan-Meier survival analysis showed that patients with malnutrition defined according to the GLIM criteria had a greater probability of 28-day mortality (log-rank, P < 0.001). Malnutrition, defined via any of the three methods, was predictive of 28-day mortality among older patients with sepsis in the emergency department. GLIM-CT had the best predictive validity.

1 November 2024 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
XZXiangqun Zhang
Xiangqun Zhang
LYLong Yang
Long Yang
JWJunyuan Wu
Junyuan Wu
XMXue Mei
Xue Mei
Background: Community-acquired pneumonia (CAP) is a significant global health issue, leading to high morbidity and mortality rates. Despite the existence of various severity scoring systems, accurately predicting patient outcomes remains challenging. The CAP-PIRO (Predisposition, Insult, Response, and Organ dysfunction) scoring system offers a comprehensive approach to evaluating CAP severity and prognosis. Objective: This study aimed to assess the effectiveness of the CAP-PIRO scoring system in predicting the prognosis and severity of CAP patients, focusing on the development of acute respiratory distress syndrome (ARDS) and 28-day mortality. Methods: A total of 875 CAP patients were prospectively enrolled from the emergency department of Beijing Chao-yang Hospital between November 2017 and December 2023. Clinical data, including patient demographics, medical history, vital signs, and laboratory findings, were collected within 6 hours of admission. CAP-PIRO, CURB-65, and PSI scores were calculated. Patients were stratified based on ARDS development, 28-day mortality, and PaO2/FiO2 categories (≤ 100 mmHg, 100– 200 mmHg, 200– 300 mmHg). Results: Significant differences were observed in PCT, blood lactate (Lac), CURB-65, PSI, and CAP-PIRO scores between patients with and without ARDS, as well as between survivors and non-survivors at 28 days (P< 0.05). CAP-PIRO and Lac were identified as independent predictors for ARDS development and 28-day mortality. The area under the ROC curve (AUC) for CAP-PIRO was higher than that for CURB-65 and PSI in predicting 28-day mortality. The combination of CAP-PIRO and Lac demonstrated improved predictive accuracy for ARDS. Notably, significant differences in CAP-PIRO scores were observed across different PaO2/FiO2 groups. Conclusion: CAP-PIRO demonstrates strong predictive ability for adverse outcomes and, when combined with lactate, shows enhanced predictive power. These findings underscore the value of CAP-PIRO for clinical risk stratification in CAP patients.

1 May 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
XZXiangqun Zhang
Xiangqun Zhang
LYLong Yang
Long Yang
YGYu Gu
Yu Gu
JWJunyuan Wu
Junyuan Wu
XMXue Mei
Xue Mei
SGShu-Bin Guo
Shu-Bin Guo
Background: Sepsis is an infection-induced systemic inflammatory response syndrome with high morbidity and mortality. β 2-microglobulin (β 2-MG), a low-molecular-weight protein involved in immune processes, shows potential for predicting the prognosis of various diseases. However, its role in sepsis prognosis remains unclear, necessitating further exploration. Objective: This study aimed to evaluate the predictive value of serum β 2-MG for 28-day mortality in sepsis patients and compare it with traditional indicators such as sequential organ failure assessment (SOFA) scores and lactate (Lac) levels. Methods: A total of 346 sepsis patients were included in this single-center retrospective study conducted at the emergency department of Beijing Chao-Yang Hospital. Clinical and biochemical indicators, including β 2-MG, SOFA scores, and Lac levels, were collected. Predictive ability was assessed using receiver operating characteristic (ROC) curve analysis and binary logistic regression models, and β 2-MG was compared to SOFA scores and Lac levels. Results: β 2-MG was significantly correlated with 28-day mortality and identified as an independent risk factor (P< 0.001, OR=1.142, 95% CI: 1.083– 1.204). The sensitivity of β 2-MG was 94%, and its specificity was 77% for predicting 28-day mortality. Combining β 2-MG with SOFA scores increased sensitivity to 94%, while combining it with Lac improved specificity to 88.9%. ROC analysis showed that β 2-MG’s predictive accuracy improved significantly when combined with these indicators. Conclusion: The serum level of β 2-MG is an independent predictor of 28-day mortality in sepsis patients. While less sensitive and specific than SOFA scores and lactate, combining β 2-MG with these markers improves predictive accuracy, offering complementary prognostic value.